Effect of Moringa oleifera Lam. Extract on NK Cells and Leukocytes of White Male Mice (Mus musculus) Exposed to Antigen Virus COVID-19
Yufri Aldi1*, Atika Mayyola1, Dira Hefni2, Afriwardi Afriwardi3,
Salman Umar4, Aditya Alqamal Alianta5
2Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Andalas, West Sumatra, Indonesia.
3Department of Physiology, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra, Indonesia.
4Department of Pharmaceutical, Faculty of Pharmacy, Universitas Andalas, Padang, West Sumatra, Indonesia.
5Department of Socio-economic, Faculty of Animal Science,
Universitas Andalas, Padang, West Sumatra, Indonesia.
*Corresponding Author E-mail: yufrialdi@phar.unand.ac.id
ABSTRACT:
Introduction: Moringa oleifera Lam. is a plant with medicinal properties. The Indonesian community widely uses it to boost the immune system. Aim: The study aimed to determine the effect of Moringa oleifera Lam. leaf extract on NK cell activity, total leukocyte cell count, and percentage of leukocyte cells in male white mice exposed to COVID-19 virus antigen. Material and Method: 25 white male mice (Mus musculus) were used in this study. In the control group, mice were given 0.5% Na-CMC for 7 days. In the treatment group, on the first and seventh days, mice were given the COVID-19 vaccine intramuscularly. Each group was given different treatments (0.5% Na-CMC, 10 mg/kg BW, 30 mg/kg BW, and 100 mg/kg BW Moringa oleifera Lam. leaf ethanol extract) orally for 7 days. NK cell activity, total leukocyte cell count, and leukocyte cell percentage were analysed on the eighth day. The data was analysed using one-way ANOVA and Duncan's New Multiple-Range Tests (DMRT). Result: The highest NK cell activity and the total amount of leukocytes were found in those given the vaccine and Moringa oleifera Lam. extract at a dose of 100 mg/kg BW. In addition, the lowest activity was in the group that was only given 0.5% Na-CMC. The One-way ANOVA Test and DMRT result showed significant differences (p<0.05) in NK cell activity, total number of leukocytes, and percentage of leukocytes in white male mice. Total leukocyte count increased in all groups compared to the Na-CMC 0.5. On the other hand, in the percentage of total leukocyte type, there was an increase in segmented neutrophils, band neutrophils, and lymphocytes. However, no increase in monocytes and eosinophils was noted in any group. Conclusion: The administration of Moringa oleifera Lam. leaf ethanol extract can increase NK cell activity, total leukocyte count, and certain leukocyte types in white male mice exposed to COVID-19 antigens.
KEYWORDS: COVID-19, Leukocytes, Moringa oleifera Lam, Mus musculus, NK Cells.
INTRODUCTION:
Indonesia is a country with a high level of biodiversity1. As many as 31,750 types of plants were discovered in Indonesia, and 25,000 were flowering plants. Also, around 15,000 plant species have potential medicinal properties, but only around 7,000 species are used as medicinal raw materials2,3. The Indonesian community utilised this high level of biodiversity, including the Moringa oleifera Lam. It is called the Miracle Plant because of its natural richness in nutritional compounds and medicinal properties not found in most other plants4,5. The Moringa oleifera Lam. leaves can be used as a traditional medicine6. They are an antitumor, lower blood pressure, antioxidant, antimicrobial, antifungal, antihypertensive, reduce inflammation, and have diuretic properties7,8,9,10,11,12.
Based on phytochemical analysis, Moringa oleifera Lam. leaves contain antioxidant compounds8. Previous research stated that the ethanol extract of Moringa oleifera Lam. leaves, based on the results of phytochemical testing, contains secondary metabolite compounds of alkaloids, flavonoids, phenolics, terpenoids and steroids but does not contain saponin compounds8,13,114. Apart from having antioxidant properties, the compounds found in Moringa oleifera Lam leaves also act as immune system regulators or immunomodulators15. The immunomodulatory properties in Moringa oleifera Lam. leaves show the same role as natural killer (NK) cells in white blood cells16.
The human body has a defence system called the immune system. This system fights foreign objects or pathogens (bacteria, viruses and other dangerous microorganisms) that can enter the body. If a pathogen manages to enter the body, the immune system will detect it as a threat. This is responded to by coordinating cells and compounds in the body to fight the pathogen17. One of the cells that play a role in the body's defence system is NK cells18.
NK cells are innate leukocytes vital in the body's defence against viral infections19,20. When an infection caused by a pathogen occurs, NK cells will play an essential role in limiting the body's immune response. NK cells will destroy activated immune cells to avoid excessive damage to the body. Thus, NK cells act as immune regulators that help maintain balance and prevent excessive immune reactions21,22.
Previous studies reported that entering the virus into the body causes the body's defence system to become active23. If the pathogen successfully passes the opsonisation process in the nose and gastrointestinal tract's mucosal lining, NK cells will protect the body. The occurrence of contact between NK cells and pathogens will produce three types of cytokines, such as granzyme, porphyrin, and interferon, to prevent viruses from entering new cells23. The immunomodulatory properties and antiviral activity of NK cells can be weakened when the body is infected with a virus, one of which is SARS-CoV-2, which causes NK cells to become exhausted, resulting in excessive activation of the immune system. This is the leading cause of pathogenesis in COVID-19 patients22.
COVID-19 is a disease caused by the coronavirus (SARS-CoV-2)24. This virus first appeared in Wuhan, China, at the end of 2019 and became a worldwide pandemic25,26,27. This virus has a higher transmission ability to spread quickly21,26. However, in May 2023, the COVID-19 pandemic was declared to have ended28. However, there are still active cases of COVID-19. Based on WHO data, in May 2023, there were 38,150 confirmed cases of COVID-19, with a total of 497 deaths29. This is because the COVID-19 virus reduces the number of NK cells circulating in the body and increases the expression of cytolytic proteins such as perforin and granzyme21. Research from Hammer et al. indicated that NK cells are essential in responding to COVID-19 infection and can respond to infection by the SARS-CoV-2 virus30.
The use of Moringa oleifera Lam. leaf extract has an impact on the immune system31. Previous research explains that administering extract ethanol from Moringa oleifera Lam. leaves can increase total leukocytes. It is proven by the percentage of white blood cells, including 2-3% eosinophil cells, 4.2-6.4% neutrophil cells, 38.8-47% lymphocyte cells, and 3-8.8% monocyte cells32.
Another research stated that Moringa oleifera Lam. leaves significantly improved the body's immune system during the COVID-19 pandemic33. Before that, another study has proved that Moringa oleifera Lam. leaf extract provides immunostimulant and immunosuppressant effects, which can increase the number of CD4+ cells and CD 8+ T cells at doses of 14 mg/kg BW, 42 mg/kg BW, and 84 mg/kg BW31. Moreover, an explanation from another research showed that giving Moringa oleifera Lam. leaf extract can increase the number of leukocyte cells with the largest total average count of 12,017 /µL of blood. An increase in leukocyte cells indicates the body's natural (non-specific) defence system, in which NK cells also play a role in the non-specific immune system34. However, no research has examined the effect of Moringa oleifera Lam. leaf extract on the activity of NK cells exposed to COVID-19 virus antigens. Therefore, it is necessary to conduct a study to test the effect of Moringa oleifera Lam. leaf extract on NK cells exposed to COVID-19 virus antigens.
MATERIALS AND METHOD:
Material:
The materials used are Moringa oleifera Lam. leaves, ethanol distillate 70% (Andalas Chemical), Ethanol 70% (Andeska Laboratory), ethanol P (Supelco), 0.5% Na-CMC (PT. Dwilab Mandiri Scientific), Aqua Pro Injection, COVID-19 vaccine (Indovac), Giemsa, immersion oil, distilled water, filter paper, aluminium foil, Silica gel F254 TLC plate, standard mouse food, Turk solution, aluminium chloride (Muda Berkah), sodium acetate (Emsure), ash-free filter paper, hydrochloric acid LP (Medical and Laboratory Supplies), quercetin (Sigma), Mouse Natural Killer Cell ELISA Kit (BT Lab).
Tools:
The tools used are measuring cups (Herma®), analytical scales (Ohaus®), animal scales (Ohaus®), animal metabolite cages, sondes, syringes (One Med®), dropper pipettes, spatula, beaker glass (Pyrex®), animal feeding and drinking containers, serum racks and tubes, stamper mortar, rotary evaporator (Buchi®), blender, funnel (Pyrex®), volumetric flask (Pyrex®), vial, watch glass, Erlenmeyer (Pyrex®), volume pipette ( Pyrex®), rack and test tubes, centrifuge (Rotovix 32®), UV-Vis spectrophotometer (Thermo Scientific Genesys 10S UV-Vis®), incubator, oven, furnace, ELISA reader (Bio-Rad®), glass slide, cover glass, and light microscope, Hot Plate, Evaporating Cup.
Preparation of Extraction:
A total of 5 kg of fresh Moringa oleifera Lam. leaves samples were sorted and cleaned from impurities, then air-dried to obtain dry samples, provided the samples could be crushed. Furthermore, powder making is carried out with a grinder without causing damage or losing the required chemical content until a fine powder of Moringa oleifera Lam. was obtained35. The powder was macerated using 70% ethanol solvent (1:10) for 24 hours with 3 repetitions. The powder was soaked for the first 6 hours while occasionally stirred and left undisturbed for 18 hours. All the macerates were collected and evaporated using a rotary evaporator to obtain a concentrated extract.
Characterisation of Moringa oleifera Lam. Extract:
Organoleptic:
Organoleptic parameters for describing the thick extract of Moringa oleifera Lam. using the five senses, namely describing the shape, colour, smell and taste in the form of thick extract, brownish green colour, distinctive odour and bitter taste. The organoleptic test observed the characteristic odour of a thick extract of Moringa oleifera Lam. It was carried out after the sample was exposed to air for 15 minutes. The 15 minutes start counting after the container containing no more than 25 g of material is opened. This is done for containers containing more than 25 g of material after approximately 25 g has been transferred into a 100 mL evaporating cup. The odour mentioned is only descriptive and is not considered a purity standard for the thick ethanol extract of Moringa oleifera Lam35.
Determination of moisture content (gravimetric method):
Weigh approximately 10 g of thick Moringa oleifera Lam. extract in a tarnished container. Samples were dried at 105°C for 5 hours and weighed. Then, continue weighing at 1-hour intervals until the yield between two consecutive weighings was less than 0.25%. The water content requirement for the thick Moringa oleifera Lam. extract is 10.0%35.
(W1 – W0) – (W2 – W0)
Moisture content = -------------------------------- x 100%
W1 – W0
Determination of total ash content:
Weigh 2 to 3 g of the extract carefully, then put it into a silicate crucible that has been ignited and tared. After that, the sample is slowly heated until the charcoal runs out, then cooled and weighed. If the charcoal cannot be removed using this process, add hot water, stir, filter through ash-free filter paper, then evaporate and incandescent until the weight remains at 800 ± 25o C in the same crucible. Calculate the ash content of the material that has been dried in the air with the following equation, and the requirement for the total ash content of the thick extract of Moringa oleifera Lam. is not more than 9.0%35 :
W2 – W0
Total ash content = --------------
W1 – W0
Determination of acid-insoluble ash content:
Boil the ash obtained to determine total ash content with 25 mL of dilute hydrochloric acid LP for 5 minutes. The acid-insoluble part is collected, filtered using ash-free filter paper, washed with hot water, and then ignited in a crucible until the weight remains at a temperature of 800 ± 25o C. Calculate the acid-insoluble ash content of the air-dried material with the following equation the following and the requirements for the acid insoluble ash content of the thick extract of Moringa oleifera Lam. which is not more than 0.9%35.
W2 - W0
Acid insoluble ash content = --------------- x 100%
W1 - W0
Preparation of Animals:
The experimental animals used were 25 male white mice aged 8-12 weeks with a body weight of 20-35 g. They had never been used for experiments and showed normal behaviour. Before the research, mice were acclimatised for 7 days to adjust to the environment, control health and body weight, and were given enough drink and food36.
Preparation of test preparations:
Dose planning:
The dose of a thick Moringa oleifera Lam extract given to white male mice was 10 mg/kg BW, 30 mg/kg BW, and 100 mg/kg BW. The dose given came from testing the immunostimulant activity of Moringa oleifera Lam. leaves at doses of 10 mg/kg BW, 30 mg/kg BW, and 100 mg/kg BW in male white mice36. There are similarities in the doses used because the researchers wanted to see the immunomodulatory activity of Moringa oleifera Lam. leaves on NK cells in male white mice exposed to the COVID-19 virus antigen.
Preparation of 0,5% Na CMC suspension:
Weigh 500 mg of Na CMC and sprinkle it on 10 mL of hot water in a heated mortar. Leave it for 15 minutes and then grind until homogeneous. Next, add aquadest until the volume is 50 mL.
Preparation of suspension of Moringa oleifera Lam. leaf ethanol extract:
Suspend 1 g of extract into 50 mL of 0,5% Na CMC. Then, dilute the test suspension according to the concentrations of each designed dose: 10 mg, 30 mg, and 100 mg. The volume of the test formulation injection should be adjusted based on the body weight of the test animals.
Administration of Test Preparations
|
Group I |
: |
Only 0.5% Na CMC is given for 7 days. |
|
Group II |
: |
Given 0.5% Na CMC for 7 days and 0.13 ml / g BW vaccine on the first day and 7th day |
|
Group III |
: |
Given the extract at a dose of 10 mg/kg BW for 7 days and 0.13 ml / g BW vaccine on the first day and 7th day |
|
Group IV |
: |
Given the extract at a dose of 30 mg/kg BW for 7 days and 0.13 ml / g BW vaccine on the first day and 7th day |
|
Group V |
: |
Given the extract at a dose of 100 mg/kg BW for 7 days and 0.13 ml / g BW vaccine on the first day and 7th day |
Examination of NK cell activity using ELISA:
Blood samples were taken by guillotine (neck artery). Blood was collected and centrifuged for 30 minutes at 3000 rpm to obtain serum. Then, the serum obtained was used to test NK cell activity using the ELISA method 40 times µL37.
Calculating the Total Number of Leukocyte Cells:
The total number of leukocyte cells was calculated after treatment, and the mice were sacrificed, namely by sucking fresh blood using a micropipette and a microtip of 0.5 µL, then Turk solution put into a microtip using a micropipette of 10 µL. Then, the Turk solution and sample were homogenised for 3 minutes, and 1-2 drops were dropped from the micropipette in the haemocytometer drip chamber. In the final step, the liquid is left for 2 minutes until the leukocytes settle and the white blood cells are counted in the four counting chambers36.
Calculating the Percentage of Total Leukocyte Count:
The percentage of the total leukocyte count was calculated by placing one drop of fresh mouse blood on the centre line of the slide, approximately 2 cm from the tip. Then, place another slide to the left of the droplet and move it to the right until a thin smear forms. After the smear preparation is dry, it is continued with fixation using methanol for 3-5 minutes and allowed to dry in air. Next, the preparation was dipped with Giemsa solution, diluted with distilled water (1:20) and left for 20 minutes. Then, the preparations were washed with running water and allowed to dry on a rack. After drying, the preparations were examined under a microscope with 1000x magnification38.
Data Analysis:
The results obtained from this research will be analysed statistically using the one-way Analysis of Variance (ANOVA) method. After that, the significant data was analysed with the Duncan Multiple Range Test (DMRT). It was analysed using the IBM SPSS 25 version.
RESULTS AND DISCUSSION:
Extraction Process and Yield of Purified Extract:
Making Moringa oleifera Lam. leaf extract begins with collecting a fresh sample. The sample used was 5 kg, then 600 g of Moringa oleifera Lam. leaf simplicia powder was obtained, and 153.22 g of Moringa oleifera Lam. leaf thick extract was obtained with a yield of 25.53%. The yield of the thick extract meets the Indonesian Herbal Pharmacopoeia requirements, which stipulates that the yield of thick extract of Moringa oleifera Lam. leaves is not less than 9.2%, so further research can be carried out.
Table 1. Moringa oleifera Lam. leaf extract yield
|
Sample weight (g) |
Extract weight (g) |
Yield (%) |
|
600 |
153.22 |
25.53% |
Organoleptic Test of Purified Extract:
The organoleptic test results showed that the ethanol extract of Moringa oleifera Lam leaves was thick, brownish green in colour, had a distinctive smell, and had a bitter taste. These results comply with the organoleptic standards for Moringa oleifera Lam. leaf extract in the Indonesian Herbal Pharmacopoeia35.
Examination of moisture content, total ash content and acid-insoluble ash content:
The examination of moisture content in the ethanol extract of Moringa oleifera Lam. leaves resulted in 9.73%. This moisture content value meets the requirements specified in the Indonesian Herbal Pharmacopoeia, which should not exceed 10%35. The examination of total ash content yielded 1.38%. The ash content value meets the requirements in the Indonesian Herbal Pharmacopoeia, which is no more than 9%35. Meanwhile, the examination of acid-insoluble ash content yielded 0.63%. This acid-insoluble ash content value complies with the requirements in the Indonesian Herbal Pharmacopoeia, which should not exceed 0.9%36.
Administration of test preparations:
Twenty-five male white mice were grouped into 5 groups, each group consisting of 5 mice. The first group was the group that was only given 0.5% Na-CMC suspension orally for 7 days. The second group, namely the group that was given 0.5% Na-CMC suspension orally for 7 days and was given the COVID-19 vaccine intramuscularly at 0.13 mL/20 g on day 1st and day 7th. The third, fourth, and fifth groups, namely the groups that were given Moringa oleifera Lam. leaf ethanol extract sequentially at doses of 10 mg/kg BW, 30 mg/kg BW, and 100 mg/kg BW, were then administered the COVID-19 vaccine intramuscularly at 0.13 mL/ 20 g BW on day first and seventh day.
Analysis of NK cell activity:
The sample used in the NK cell examination is serum from a centrifuge of blood samples taken by guillotine (neck artery). Blood was collected and centrifuged for 30 minutes at 3000 rpm to obtain serum. Then, the serum was used to test NK cell activity using the ELISA method with 40 ul of serum. Anti-KLRD1 antibodies, or CD94, are used to test NK cell activity. CD94 is part of a receptor essential for MHC-I recognition in NK cells. Suppose cells do not express MHC class I or express them in insufficient amounts (infected cells). In that case, CD94 can activate NK cells to respond and destroy these cells39. The use of CD94 in ELISA may help understand the role of NK cells in disease pathogenesis or response to specific therapies. By obtaining CD94 absorbance and making it into a concentration, results can be obtained that show the activity of NK cells.
Table 2. Absorbance of CD94
|
Group |
Absorbance of CD94 |
||||
|
1 |
0.478 |
0.479 |
0.467 |
0.461 |
0.475 |
|
2 |
0.474 |
0.477 |
0.465 |
0.478 |
0.463 |
|
3 |
0.478 |
0.482 |
0.483 |
0.488 |
0.482 |
|
4 |
0.492 |
0.497 |
0.49 |
0.489 |
0.471 |
|
5 |
0.524 |
0.522 |
0.527 |
0.54 |
0.538 |
Based on the results of the average CD94 concentration, it shows that from several treatment groups given varying doses of Moringa oleifera Lam. leaf ethanol extract and induced with the COVID-19 vaccine, the highest NK cell activity was in group 5, as much as 2.9806 μg/mL and the lowest activity was in group 1, which was only given 0.5% Na-CMC without any extract, as much as 2.9462 μg/mL. After carrying out the one-way ANOVA statistical test, there was a significant difference in the values (p<0.05). The DMRT results showed that administering the vaccine with ethanol extract of Moringa oleifera Lam. leaves 100 mg/kg BW was more effective than the other groups. NK cells are vital cells in the body's non-specific immune system. NK cells function to kill infected cells and destroy activated immune cells to avoid excessive damage to the body. Thus, NK cells act as immune regulators that help maintain balance and avoid excessive immune reactions21.
Calculating the total number of leukocyte cells:
Based on the results of the average count of total leukocytes, it was found that leukocytes had increased in all groups compared to the group that was only given 0.5% Na-CMC.
Table 3. Average total number of leukocytes
|
Group |
Average total amount (µL) |
|
1 |
6,200 |
|
2 |
12,390 |
|
3 |
15,420 |
|
4 |
20,620 |
|
5 |
24,900 |
An increase in total leukocyte cells proves that the body's defence system is natural or non-specific40. The results of the one-way ANOVA statistical test showed that there were significant differences (p<0.05). To understand these differences, statistical analysis was continued with the DMRT. The results show that each group is not in the same subset. This states that administering vaccines and Moringa oleifera Lam. leaf ethanol extract with varying doses influences increasing total leukocyte cells.
Figure 1. Leukocyte cells in a hemacytometer counting chamber
Based on Figure 1, it can be explained that this is one of the counting rooms in the hemacytometer. The total number of leukocytes was obtained by counting the four hemacytometer chambers using the L rule method. Therefore, leukocytes on the right and upper lines do not need to be counted to avoid counting twice.
Table 4. Average type of leukocyte
|
Group |
Segmental Neutrophils |
Stem Neutrophils |
Lymphocytes |
Monocytes |
Eosinophils |
|
1 |
31.8 |
13.6 |
32.6 |
11.4 |
10.6 |
|
2 |
33.2 |
13.8 |
34 |
10 |
9 |
|
3 |
34.8 |
14.4 |
36.2 |
5 |
9.6 |
|
4 |
36.8 |
17.8 |
37.2 |
5.4 |
2.8 |
|
5 |
37.8 |
18 |
38 |
3.8 |
2,4 |
Figure 2. Leukocyte cells under a microscope with 1000x magnification. (a) Segmental neutrophils; (b) Stem neutrophils; (c) Lymphocytes; (d) Monocytes; (e) Eosinophils
Calculating the Percentage of Total Leukocyte Count:
The purpose of this analysis is to determine the effect of the extract on its ability to stimulate the immune response. The purpose of making thin smears is to make it easier to observe and count leukocyte cells, allowing leukocyte cells to spread evenly on a glass slide so that leukocyte cells can be observed clearly and accurately. Giemsa solution is used to clarify the differences between leukocyte cells, namely segment neutrophils, rod neutrophils, lymphocytes, monocytes and eosinophils. Meanwhile, basophils are alkaline and dissolve in Giemsa solution, so they cannot be seen during analysis. After drying, the preparations were examined under a microscope with 1000x magnification using immersion oil to determine the shape of leukocyte cells40. It showed in Figure 2 below. Calculation of the percentage of leukocyte cells is done by cross-sectioning or counting leukocytes starting from the tail end of the blood smear by snaking until 100 leukocyte cells are obtained, then expressed as a percentage41.
From Table 4, the average percentage of leukocyte types found in each group with different treatments was obtained. The significant difference in the results of monocytes and eosinophils from white male mice between the groups given 0.5% Na-CMC, the COVID-19 vaccine, and varying doses of Moringa oleifera Lam. leaf ethanol extract was due to the group only being given 0.5% Na-CMC without vaccine does not cause significant immune stimulation, so the results of monocytes and eosinophils are relatively higher because there is no decrease due to the specific immune response to the vaccine. In the group given the COVID-19 vaccine together with 0.5% Na-CMC, the immune response induced by the vaccine could cause changes in the leukocyte population, including a decrease in eosinophils because vaccines usually trigger a specific inflammatory response. Meanwhile, when administering a vaccine with Moringa oleifera Lam. leaf ethanol extract at a dose of 100 mg/kg BW, which is the highest dose, the immune system may develop an adaptation; certain cells, such as monocytes and eosinophils, decrease in response to excessive stimulation. This is the body's protective mechanism to avoid cell activation that could damage the body's own tissue42.
CONCLUSIONS:
Based on the results of the research that has been carried out, it can be concluded that the administration of ethanol extract of Moringa oleifera Lam. influenced increasing NK cell activity in male white mice exposed to COVID-19 virus antigens. It influenced increasing the total number of leukocyte cells in male white mice exposed to the COVID-19 virus antigen. Administering of ethanol extract of Moringa oleifera Lam. affected increasing the percentage of segment neutrophil cells, stem neutrophils, and lymphocytes and did not increase the percentage of monocyte and eosinophil cells in male white mice exposed to COVID-19 virus antigens.
CONFLICT OF INTEREST:
The authors declare no conflict of interest.
ACKNOWLEDGEMENT:
The authors thank the Rector Universitas Andalas through the Institute for Research and Service Society (LPPM Unand). The research was made possible and financially supported under "Penelitian Unggulan Jalur Kepakaran (PUJK), Batch I, the Year 2024, with contract number: 381/UN.16.19/PT.01.03/PUJK/2024 signed on 17 July 2024.
REFERENCES:
1. Rambey R, Susilowati A, Rangkuti AB, Onrizal O, Desrita D, Ardi R, Hartanto A. Plant diversity, structure and composition of vegetation around Barumun Watershed, North Sumatra, Indonesia. Biodiversitas Journal of Biological Diversity. 2021; Jul 17; 22(8). https://doi.org/10.13057/biodiv/d220819
2. Setiawan A. Keanekaragaman hayati Indonesia: Masalah dan upaya konservasinya. Indonesian Journal of Conservation. 2022; 11(1): 13-21. https://doi.org/10.15294/ijc.v11i1.34532
3. Navnath NS. Moringa oleifera: A Review on Medicinal Properties and Their Commercial Applications. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(2): 125-128. https://doi.org/10.52711/2231-5659.2024.00030
4. Marhaeni LS. Daun Kelor (Moringa oleifera) sebagai Sumber Pangan Fungsional dan Antioksidan. AGRISIA-Jurnal Ilmu-Ilmu Pertanian. 2021; 13(2). Retrieved from: https://ejournal.borobudur.ac.id/index.php/3/article/view/882
5. Pachava VR, Krishnamurthy PT, Dahapal SP, Chinthamaneni PK. An updated review on “Miracle tree”: Moringa oleifera. Research Journal of Pharmacognosy and Phytochemistry (RJPP). 2018; 10(1): 101-108. https://doi.org/10.5958/0975-4385.2018.00016.X
6. Isyraqi NA, Rahmawati D, Sastyarina Y. Studi Literatur: Skrining Fitokimia dan Aktivitas Farmakologi Tanaman Kelor (Moringa oleifera Lam). In Proceeding of Mulawarman Pharmaceuticals Conferences 16 December 2020 (Vol. 12, pp. 202-210). Retrieved from: https://prosiding.farmasi.unmul.ac.id
7. Sulasmi, Khalishah AN, Mawarni B, Hidayati L, Dhiya SS. Pemanfaatan Daun Kelor (Moringa oleifera L.) Untuk Mengatasi Anemia. Jurnal Pengemas Kesehatan. 2023; Feb 24; 2(1): 18-25. https://doi.org/10.52299/jpk.v2i1
8. Masum, NHMd, Hamid K, Zulfiker AHMd, Hossain MdK, Urmi KF. In vitro Antioxidant Activities of Different parts of the Plant Moringa oleifera Lam. Research Journal of Pharmacy and Technology. 2012. 5(12): 1532-1537.
9. Shukla, P., Tiwari, A. K., and Mishra, P. Study on Moringa oleifera Lam. Syn. Seed as a Ecofriendly Coagulant and Antimicrobial agent for Water Purification. Research Journal of Science and Technology, 2016. 8(1), 45-50. https://doi.org/10.5958/2349-2988.2016.00006.1
10. Namitha R, Anjitha A. Isolation and Antimicrobial Screening of Some Phytochemicals from Moringa oleifera Lam. Research. Journal Pharmacognosy and Phytochemical. 2019; 11(2): 70-72. https://doi.org/10.5958/0975-4385.2019.00013.X
11. Devi G, Suryadevara TN, Divyabharathi, Gopinath, Velaga LRVSAR, Ponmurugan P. Efficacy of Moringa oleifera’s Therapeutic Compounds and its Antimicrobial Activity. Research Journal Pharmacy and Technology. 2020; 13(8): 3867-3872. https://doi.org/10.5958/0974-360X.2020.00684.8
12. Mali S, Bendre S, Patil S. Overview of Pharmacognostical and Pharmacological properties of Moringa oleifera. Asian Journal of Pharmacy and Technology. 2022; 12(1): 77-83. https://doi.org/10.52711/2231-5713.2022.00013
13. Aldi Y, Permatasari D, Afdalanita S, Alianta AA. Safety Evaluation of Moringa Leaves (Moringa oleifera Lam.) on Kidney Organs in Male White Rats. Research Journal of Pharmacy and Technology. 2024; 17(11):5531-5539. https://doi.org/10.52711/0974-360X.2024.00845
14. Aldi Y, Aisyah A, Abdillah R, Alianta AA. Activity of Moringa Oleifera Lam on Liver Function and Histology in White Male Rats. Pharmacognosy Journal. 2023; 15(5). http://dx.doi.org/10.5530/pj.2023.15.174
15. Husni E, Badriyya E, Putri L, Aldi Y. The effect of ethanol extract of moringa leaf (moringa oleifera lam) against the activity and capacity of phagocytosis of macrofag cells and the percentage of leukosit cells of white mice. Pharmacognosy Journal. 2021; 13(3). http://dx.doi.org/10.5530/pj.2021.13.90
16. Mehwish HM, Riaz Rajoka MS, Xiong Y, Zheng K, Xiao H, Anjin T, Liu Z, Zhu Q, He Z. Moringa oleifera–a functional food and its potential immunomodulatory effects. Food Reviews International. 2022; Oct 3; 38(7): 1533-52. https://doi.org/10.1080/87559129.2020.1825479
17. Adijaya O, Bakti AP. Peningkatan sistem imunitas tubuh dalam menghadapi Pandemi COVID-19. Jurnal Kesehatan Olahraga. 2021 Sep;9(03):51-60. Retrieved from: https://ejournal.unesa.ac.id/index.php/jurnal-kesehatan-olahraga/article/view/40767
18. Ratajczak W, Niedźwiedzka-Rystwej P, Tokarz-Deptuła B, Deptuła W. Immunological memory cells. Central European Journal of Immunology. 2018; Apr 1; 43(2): 194-203. https://doi.org/10.5114/ceji.2018.77390
19. Abel AM, Yang C, Thakar MS, Malarkannan S. Natural killer cells: development, maturation, and clinical utilisation. Frontiers in immunology. 2018; Aug 13; 9: 1869. https://doi.org/10.3389/fimmu.2018.01869
20. Fitriah M, Tambunan BA, Kahar H, Nugraha J, Aulia FA, Aryati, Yudhawati R, Sudarsono, Tinduh D, Prakoeswa CRS, Hernaningsih Y. Characteristics of Natural Killer (NK) Cell and T Lymphocyte in COVID-19 patients in Surabaya, Indonesia. Research Journal of Pharmacy and Technology. 2022; 15(5):2198-2203. https://doi.org/10.52711/0974-360X.2022.00365
21. Zafarani A, Razizadeh MH, Pashangzadeh S, Amirzargar MR, Taghavi-Farahabadi M, Mahmoudi M. Natural killer cells in COVID-19: from infection to vaccination and therapy. Future Virology. 2023; Feb; 18(3): 177-91. https://doi.org/10.2217/fvl-2022-0040
22. Gadge SS. Antiviral and Immunity-modulating Natural Herbs in the Prevention of COVID-19. Research Journal of Pharmacognosy and Phytochemistry. 2021; 13(2): 81-94. https://doi.org/10.52711/0975-4385.2021.00014
23. Aldi Y, Salman S, Badriyah E, Alianta AA, Husni E. Pembuatan Obat Tradisional Berbahan Pegagan Embun Bagi Masyarakat Di Kenagarian VII Koto Talago Kecamatan Guguk Kabupaten 50 Kota. Jurnal Hilirisasi IPTEKS. 2022; Dec 31; 5(4): 237-46. https://doi.org/10.25077/jhi.v5i4
24. Naresh BV. A Review of the 2019 Novel Coronavirus (COVID-19) Pandemic. Asian Journal Pharmaceutical Research. 2020; 10(3):233-238. https://doi.org/10.5958/2231-5691.2020.00040.4
25. Sari MK. Sosialisasi tentang pencegahan covid-19 di kalangan siswa sekolah dasar di SD Minggiran 2 Kecamatan Papar Kabupaten Kediri. Jurnal Karya Abdi Masyarakat. 2020 Jun 30;4(1):80-3. https://doi.org/10.22437/jkam.v4i1.9821
26. Manish Kumar Balai. UK Variant COVID-19. Asian Journal of Nursing Education and Research. 2021; 11(4): 601-604. https://doi.org/10.52711/2349-2996.2021.00140
27. Ahmad S, Shoaib A, Ali S, Alam S, Alam N, Ali M, Mujtaba A, Ahmad A, Ansari, S, Ali MD. Epidemiology, risk, myths, pharmacotherapeutic management and socio economic burden due to novel COVID-19: A recent update. Research Journal Pharmacy and Technology. 2020; 13(9): 4435-4442. https://doi.org/10.5958/0974-360X.2020.00784.2
28. Sarker R, Roknuzzaman ASM, Nazmunnahar, Shahriar M, Hossain MJ, Islam MR. The WHO has declared the end of pandemic phase of COVID-19: Way to come back in the normal life. Health Sci Rep. 2023; Sep 5; 6(9): e1544. https://doi.org/10.1002/hsr2.1544
29. WHO. COVID-19 Weekly Epidemiological Update. Edition 144 Published 25 May 2023. Retrieved from https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---25-may-2023
30. Hammer Q, Cuapio A, Bister J, Björkström NK, Ljunggren HG. NK cells in COVID-19—from disease to vaccination. Journal of Leukocyte Biology. 2023; Nov; 114(5): 507-12. https://doi.org/10.1093/jleuko/qiad031
31. Listiani N, Susilawati Y. Review Artikel: Potensi tumbuhan sebagai imunostimulan. Farmaka. 2019; 17(2): 222-31. https://doi.org/10.24198/farmaka.v17i2.22045.g11638
32. Salsabila AA. Uji Aktivitas Ekstrak Etanol Daun Kelor (Moringa Oleifera Lam) Terhadap Aktivitas Dan Kapasitas Fagositosis Makrofag Pada Mencit Yang Divaksinasi Dengan Vaksin H5N1 (Unpublished Bachelor Theses of Universitas Perintis Indonesia “UPERTIS”).
33. Fajri M. The potential of Moringa oleifera as immune booster against COVID 19. IOP Conference Series: Earth and Environmental Science, Volume 807, Adapting Agricultural Production to Covid-19. 2021 Jul 1 (Vol. 807, No. 2, p. 022008). IOP Publishing. https://doi.org/10.1088/1755-1315/807/2/022008
34. Mutia F, Aldi Y, Dillasamola D. Uji Efek Imunomodulator Dari Ekstrak Daun Kelor (Moringa Oleifera L.) dengan Metoda Carbon Clearance terhadap Mencit Putih Jantan 2022. (Unpublished Bachelor Theses of Universitas Andalas).
35. Kemenkes RI. Farmakope Herbal Indonesia Edisi II. Jakarta: Kementrian Kesehatan Republik Indonesia or Ministry of Health of Indonesia Republic. 2017. Retrieved from: https://farmalkes.kemkes.go.id/2020/08/farmakope-herbal-indonesia-edisi-ii-tahun-2017-3/#
36. Dillasamola D, Aldi Y, Fakhri M, Diliarosta S, Biomechy OP. Immunomodulatory effect test from moringa leaf extract (Moringa oleifera L.) with carbon clearance method in male white mice. Asian Journal Pharmaceutical Clinic Research. 2018; Sep 7; 11(9): 241-5. https://doi.org/10.22159/ajpcr.2018.v11i9.26703
37. Umar S, Gusriyani S, Afriwardi A, Aldi Y. Activities of Hydrocotyle sibthorpioides Lam. Extract in Capsule on Natural Killer and CD8 Cells in Human. Tropical Journal of Natural Product Research. 2023; Aug 1; 7(8). http://www.doi.org/10.26538/tjnpr/v7i8.29
38. Aldi Y, Aria M, Erman L. Uji efek imunostimulasi ekstrak etanol herba ciplukan (Physalis angulata L.) terhadap aktivitas dan kapasitas fagositosis sel makrofag pada mencit putih betina. Scientia. 2014; 4(1): 38-42. Retrieved from https://scholar.archive.org/work/peovizlsvzhhjl2nup4xxg3dqe/access/wayback/http://www.jurnalscientia.org/index.php/scientia/article/download/78/109
39. Ghasemzadeh M, Ghasemzadeh A, Hosseini E. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice. Human immunology. 2022; Jan 1; 83(1): 86-98. https://doi.org/10.1016/j.humimm.2021.09.004
40. Rahman H, Aldi Y, Mayanti E. Aktifitas imunomodulator dan jumlah sel leukosit dari ekstrak kulit buah naga merah (Hylocereus lemairei (Hook.) Britton and Rose) pada mencit putih jantan. Jurnal Farmasi Higea. 2017; Mar 2; 8(1): 44-58. http://dx.doi.org/10.52689/higea.v8i1.137
41. Ardina R, Rosalinda S. Morfologi eosinofil pada apusan darah tepi menggunakan pewarnaan Giemsa, Wright, dan kombinasi Wright-Giemsa. Jurnal Surya Medika (JSM). 2018; Feb 1; 3(2): 5-12. https://doi.org/10.33084/jsm.v3i2.91
42. Syofyan S, Almahdy A, Rachmaini F, Dillasamola D. The immunostimulatory effects of Peronema canescens. Jack leaves extract in Mus musculus L. using the carbon clearance method. Tropical Journal of Natural Product Research. 2024; Jun 5; 8(3): 6503-7. https://doi.org/10.26538/tjnpr/v8i3.
|
Received on 28.11.2024 Revised on 17.03.2025 Accepted on 11.05.2025 Published on 08.11.2025 Available online from November 13, 2025 Research J. Pharmacy and Technology. 2025;18(11):5447-5454. DOI: 10.52711/0974-360X.2025.00785 © RJPT All right reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|